SH-5
Based on 1 publication(s) in Google Scholar
SH-5 is a potent AKT inhibitor. SH-5 potentiates the apoptosis induced by tumor necrosis factor. SH-5 blocks NF-kB activation induced by TNF-a, lipopolysaccharide (HY-D1056), phorbol ester (HY-18739), and cigarette smoke.
For research use only. We do not sell to patients.
- CAS No.: 701976-54-7
- Formula: C29H59O10P
- Molecular Weight:598.75
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) SH-5
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 184B5 | GI50 |
10.35 μM
Compound: 2
|
Cytotoxicity against human 184B5 cells at 10 uM chloroquine by SRB assay
Cytotoxicity against human 184B5 cells at 10 uM chloroquine by SRB assay
|
[PMID: 18691894] |
| 184B5 | GI50 |
13.76 μM
Compound: 2
|
Cytotoxicity against human 184B5 cells by SRB assay
Cytotoxicity against human 184B5 cells by SRB assay
|
[PMID: 18691894] |
| 184B5 | GI50 |
8.98 μM
Compound: 2
|
Cytotoxicity against human 184B5 cells at 20 uM chloroquine by SRB assay
Cytotoxicity against human 184B5 cells at 20 uM chloroquine by SRB assay
|
[PMID: 18691894] |
| MCF7 | GI50 |
15.64 μM
Compound: 2
|
Cytotoxicity against human MCF7 cells in presence of 10 uM chloroquine by SRB assay
Cytotoxicity against human MCF7 cells in presence of 10 uM chloroquine by SRB assay
|
[PMID: 18691894] |
| MCF7 | GI50 |
16.01 μM
Compound: 2
|
Cytotoxicity against human MCF7 cells by SRB assay
Cytotoxicity against human MCF7 cells by SRB assay
|
[PMID: 18691894] |
| MCF7 | GI50 |
7.94 μM
Compound: 2
|
Cytotoxicity against human MCF7 cells in presence of 20 uM chloroquine by SRB assay
Cytotoxicity against human MCF7 cells in presence of 20 uM chloroquine by SRB assay
|
[PMID: 18691894] |
| MDA-MB-231 | GI50 |
14.67 μM
Compound: 2
|
Cytotoxicity against human MDA-MB-231 cells in presence of 10 uM chloroquine by SRB assay
Cytotoxicity against human MDA-MB-231 cells in presence of 10 uM chloroquine by SRB assay
|
[PMID: 18691894] |
| MDA-MB-231 | GI50 |
16.77 μM
Compound: 2
|
Cytotoxicity against human MDA-MB-231 cells by SRB assay
Cytotoxicity against human MDA-MB-231 cells by SRB assay
|
[PMID: 18691894] |
| MDA-MB-231 | GI50 |
9.39 μM
Compound: 2
|
Cytotoxicity against human MDA-MB-231 cells in presence of 20 uM chloroquine by SRB assay
Cytotoxicity against human MDA-MB-231 cells in presence of 20 uM chloroquine by SRB assay
|
[PMID: 18691894] |
| MDA-MB-468 | GI50 |
0.06 μM
Compound: 2
|
Cytotoxicity against human MDA-MB-468 cells in presence of 20 uM chloroquine by SRB assay
Cytotoxicity against human MDA-MB-468 cells in presence of 20 uM chloroquine by SRB assay
|
[PMID: 18691894] |
| MDA-MB-468 | GI50 |
19.26 μM
Compound: 2
|
Cytotoxicity against human MDA-MB-468 cells in presence of 10 uM chloroquine by SRB assay
Cytotoxicity against human MDA-MB-468 cells in presence of 10 uM chloroquine by SRB assay
|
[PMID: 18691894] |
| MDA-MB-468 | GI50 |
28.43 μM
Compound: 2
|
Cytotoxicity against human MDA-MB-468 cells by SRB assay
Cytotoxicity against human MDA-MB-468 cells by SRB assay
|
[PMID: 18691894] |
In Vitro
SH-5 (5 µM; 4+24 h) increases the cytotoxicity with 1 nM TNF in H1299 cells[1].
SH-5 (5 µM; 4+0, 6, 12, 18, 24 h) potentiates the apoptosis induced by tumor necrosis factor (TNF) in H1299 cells[1].
SH-5 (1, 3, 5 µM) inhibits TNF (1 nM; 24 h)-induced COX-2 gene expression in a dose-dependent manner[1].
SH-5 (5 µM; 4+0, 6, 12, 18, 24 h) decreases the protein expression of 1 nM TNF-induced IAP-1, XIAP, Bcl-Xl, Bcl-2, TRAF1, Survivin, COX-2, Cyclin D1, MMP-9 in a time-dependent manner in KBM-5 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:H1299 cells
-
Concentration:5 µM
-
Incubation Time:4+0, 6, 12, 18, 24 h
-
Result:Increased the protein expression of Cleaved-PARP in a time-dependent manner.
Chemical Information
-
CAS No. 701976-54-7
-
Molecular Weight 598.75
-
Formula C29H59O10P
-
SMILES
CCCCCCCCCCCCCCCCCCOC[C@@H](OC)COP(O[C@@H]1[C@@H](C[C@H]([C@@H]([C@H]1O)O)O)OC)(O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)